Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer

被引：58

作者：

Akkiprik, Mustafa ^{[2
]}

Feng, Yumei ^{[3
,4
]}

Wang, Huamin ^{[1
]}

Chen, Kexin ^{[5
]}

Hu, Limei ^{[1
]}

Sahin, Aysegul ^{[1
]}

Krishnamurthy, Savitri ^{[1
]}

Ozer, Ayse ^{[2
]}

Hao, Xishan ^{[3
,4
,5
]}

Zhang, Wei ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA

[2] Marmara Univ, Sch Med, Dept Med Biol, TR-34668 Istanbul, Turkey

[3] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin 300060, Peoples R China

[4] Tianjin Med Univ, Canc Inst & Hosp, Minist Educ, Breast Canc Prevent & Treatment Key Lab, Tianjin 300060, Peoples R China

[5] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin 300060, Peoples R China

来源：

BREAST CANCER RESEARCH | 2008年 / 10卷 / 04期

关键词：

D O I：

10.1186/bcr2116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The insulin-like growth factor axis, which has been shown to protect cells from apoptosis, plays an essential role in normal cell physiology and in cancer development. The family of insulin-like growth factor binding proteins (IGFBPs) has been shown to have a diverse spectrum of functions in cell growth, death, motility, and tissue remodeling. Among the six IGFBP family members, IGFBP-5 has recently been shown to play an important role in the biology of breast cancer, especially in breast cancer metastasis; however, the exact mechanisms of action remain obscure and sometimes paradoxical. An in-depth understanding of IGFBP-5 would shed light on its potential role as a target for breast cancer therapeutics.

引用

页数：14

共 149 条

[1] Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration [J].

Abrass, CK ;

Berfield, AK ;

Andress, DL .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (06) :F899-F906

[2] Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray [J].

Akkiprik, Mustafa ;

Nicorici, Daniel ;

Cogdell, David ;

Jia, Yu Jack ;

Hategan, Andrea ;

Tabus, Ioan ;

Yli-Harja, Olli ;

Yu, Dihua ;

Sahin, Aysegul ;

Zhang, Wei .

TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2006, 5 (06) :543-551

[3] Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF) binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action [J].

Allan, GJ ;

Tonner, E ;

Szymanowska, M ;

Shand, JH ;

Kelly, SM ;

Phillips, K ;

Clegg, RA ;

Gow, IF ;

Beattie, J ;

Flint, DJ .

ENDOCRINOLOGY, 2006, 147 (01) :338-349

[4]

ALLANDER SV, 1994, J BIOL CHEM, V269, P10891

[5] Identification and characterization of novel IGFBP5 interacting protein: evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation [J].

Amaar, YG ;

Tapia, B ;

Chen, ST ;

Baylink, DJ ;

Mohan, S .

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (03) :C900-C906

[6] Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation [J].

Amaar, YG ;

Baylink, DJ ;

Mohan, S .

JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) :1430-1439

[7] Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2) [J].

Amaar, YG ;

Thompson, GR ;

Linkhart, TA ;

Chen, ST ;

Baylink, DJ ;

Mohan, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12053-12060

[8] GLYCOSAMINOGLYCANS INHIBIT DEGRADATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-5 [J].

ARAI, T ;

ARAI, A ;

BUSBY, WH ;

CLEMMONS, DR .

ENDOCRINOLOGY, 1994, 135 (06) :2358-2363

[9]

ARAI T, 1994, J BIOL CHEM, V269, P20388

[10] Nuclear hormone receptors and gene expression [J].

Aranda, A ;

Pascual, A .

PHYSIOLOGICAL REVIEWS, 2001, 81 (03) :1269-1304

← 1 2 3 4 5 6 7 8 9 10 →